WATCH: Inside the Cancer Calculus investigation — a live Q&A

May 21, 2026 - 06:40
WATCH: Inside the Cancer Calculus investigation — a live Q&A

The International Consortium of Investigative Journalists hosted a live virtual discussion exploring findings of its Cancer Calculus investigation.

The event featured ICIJ chief reporter Sydney P. Freedberg and Serif Health health economist and senior director of analytics Bill Pajerowski. ICIJ digital producer Carmen Molina Acosta led the discussion.

Drawing on reporting with 47 media partners around the world, the Cancer Calculus investigation examines how pharmaceutical industry practices tied to patents, pricing and billing can drive up costs and limit access to lifesaving cancer treatment. The conversation included behind-the-scenes insights into the reporting, key findings from the investigation and why they matter, discussion of broader pharmaceutical pricing practices and an audience Q&A.

For your invitation to future events, please subscribe to ICIJ’s newsletter or consider making a donation to support our work.

Photo of three patients sitting in chairs with IV drip bags, with nurses doing paperwork in the foreground.

SUMMIT, NJ - OCTOBER 2: A Merck flag flies in front of the company's building on October 2, 2013 in Summit, New Jersey. The pharmaceutical company Merck & Co. announced today that it would cut 8,500 jobs and consolidate its real estate in Kenilworth, New Jersey instead of moving its headquarters to Summit as previously planned.

https://www.icij.org/investigations/cancer-calculus/following-the-paper-trail-to-guatemala-to-uncover-what-records-cant-reveal-about-access-to-keytruda/

BEHIND THE SCENES Following the paper trail to Guatemala to uncover what records can’t reveal about access to Keytruda May 11, 2026

https://www.icij.org/investigations/cancer-calculus/video-keytruda-merck-patients-patents/

VIDEO WATCH: How Merck keeps Keytruda prices sky-high Apr 13, 2026

https://www.icij.org/investigations/cancer-calculus/unacceptable-lawmakers-react-to-revelations-from-icijs-cancer-calculus-investigation/

IMPACT ‘Unacceptable’: Lawmakers react to revelations from ICIJ’s Cancer Calculus investigation Apr 23, 2026

Recommended reading BEHIND THE SCENES Following the paper trail to Guatemala to uncover what records can’t reveal about access to Keytruda May 11, 2026 VIDEO WATCH: How Merck keeps Keytruda prices sky-high Apr 13, 2026 IMPACT ‘Unacceptable’: Lawmakers react to revelations from ICIJ’s Cancer Calculus investigation Apr 23, 2026